Cyclophosphamide as a first-line therapy in LGL leukemia
2013 · Leukemia · 97 citations
https://doi.org/10.1038/leu.2013.359
M
Mikaël Roussel
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
164
Papers
3.5K
Citations
32
h-index
63
i10-index
Mikaël Roussel is an academic researcher from Inserm. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Immune cells in cancer & Immune Cell Function and Interaction. The author has an h-index of 32, co-authored 140 publications.
ORCID: 0000-0002-9741-0668Papers by this author
worksVenoarterial extracorporeal membrane oxygenation induces early immune alterations
2021 · Critical Care · 53 citations
https://doi.org/10.1186/s13054-020-03444-x
Relevance of cyclin D1b expression and CCND1polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
2006 · BMC Cancer · 32 citations
https://doi.org/10.1186/1471-2407-6-238
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection
2021 · Cell Reports Medicine · 28 citations
https://doi.org/10.1016/j.xcrm.2021.100291
Protocol for phenotyping mouse myeloid and lymphoid cells by mass cytometry
2025 · STAR Protocols · 2 citations
https://doi.org/10.1016/j.xpro.2025.103684
CORRELATION BETWEEN PRE-TREATMENT LEVEL OF SOLUBLE PD-L1 AND OUTCOME IN CLASSICAL HODGKIN LYMPHOMA INCLUDED IN A PROSPECTIVE STUDY OF THE LYMPHOMA STUDY ASSOCIATION
2016 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat